Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography

After a successful inaugural WOS in 2024, the congress will feature new lectures and wetlabs in its sophomore year

Prophylactic cyclosporine A 0.1% eye drops were associated with improved ocular surface homeostasis and reduced inflammation

SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial

A large-scale study indicates women are more likely to develop the inherited corneal condition

The UN Friends of Vision group meeting coincided with International Women's Day and the UN Commission on the Status of Women

A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden

Urcosimod, formerly known as OK-101, showed clear statistical significance in multiple endpoints in a recently completed Phase 2 trial

Additionally, the prognosis of macular oedema may help clinicians evaluate renal function, investigators reported

Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2

The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension

The event will include presentations on artificial intelligence, ocular imaging and surgical topics

The Australia-based organisation is partnering with the UN Friends of Vision group for an event on 11 March

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

The toric IOLs demonstrated a slight advantage over FSAK and were associated with better postoperative uncorrected distance visual acuity

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease